| RS2108566215 |
IQCB1
|
Health Risk |
Likely pathogenic |
Senior-Loken syndrome 5, Senior-Loken syndrome 5 |
| RS2108569910 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2108571563 |
IQCB1
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2108576783 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS2108577268 |
MYLK
|
Health Risk |
Likely pathogenic |
Isolated thoracic aortic aneurysm, Isolated thoracic aortic aneurysm |
| RS2108578389 |
MYLK
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 7 |
| RS2108591614 |
IQCB1
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2108595322 |
IQCB1
|
Health Risk |
Likely pathogenic |
Senior-Loken syndrome 5, Senior-Loken syndrome 5 |
| RS2108617673 |
THPO
|
Health Risk |
Pathogenic |
Thrombocytopenia, Thrombocytopenia |
| RS2108622234 |
RNF13
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 73 |
| RS2108622433 |
RNF13
|
Health Risk |
Likely pathogenic |
— |
| RS2108623965 |
THPO
|
Health Risk |
Pathogenic/Likely pathogenic |
Thrombocythemia 1, Thrombocythemia 1 |
| RS2108636142 |
MYLK
|
Health Risk |
Likely pathogenic |
— |
| RS2108636995 |
TP63
|
Health Risk |
Pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS2108638585 |
TP63
|
Health Risk |
Likely pathogenic |
Split hand-foot malformation 4, Split hand-foot malformation 4 |
| RS2108643149 |
NRROS
|
Health Risk |
Pathogenic |
Seizures, early-onset |
| RS2108643223 |
IQCB1
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2108644029 |
RNF168
|
Health Risk |
Pathogenic |
— |
| RS2108657396 |
RNF168
|
Health Risk |
Pathogenic |
— |
| RS2108657437 |
RNF168
|
Health Risk |
Pathogenic |
— |
| RS2108658339 |
CLDN16
|
Health Risk |
Likely pathogenic |
Primary hypomagnesemia, Primary hypomagnesemia |
| RS2108670592 |
CLDN16
|
Health Risk |
Likely pathogenic |
Primary hypomagnesemia, Primary hypomagnesemia |
| RS2108677025 |
CCDC50
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 44, Autosomal dominant nonsyndromic hearing loss 44 |
| RS2108740086 |
IFT122
|
Health Risk |
Pathogenic |
Cranioectodermal dysplasia 1, Cranioectodermal dysplasia 1 |
| RS2108743641 |
CRYGS
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2108749184 |
RHO
|
Health Risk |
Pathogenic |
— |
| RS2108749238 |
RHO
|
Health Risk |
Pathogenic |
— |
| RS2108749253 |
RHO
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2108749285 |
RHO
|
Health Risk |
Pathogenic |
— |
| RS2108749332 |
RHO
|
Health Risk |
Likely pathogenic |
— |
| RS2108749341 |
RHO
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2108749921 |
RHO
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS2108749979 |
RHO
|
Health Risk |
Likely pathogenic |
— |
| RS2108750013 |
RHO
|
Health Risk |
Likely pathogenic |
— |
| RS2108750367 |
RHO
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 4, Retinitis pigmentosa 4 |
| RS2108767230 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108770774 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108772656 |
ATP2C1
|
Health Risk |
Likely pathogenic |
— |
| RS2108773003 |
PAK2
|
Health Risk |
Pathogenic |
Knobloch syndrome, Knobloch syndrome |
| RS2108777040 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108777701 |
MSX1
|
Health Risk |
Pathogenic |
Hypoplastic enamel-onycholysis-hypohidrosis syndrome, Hypoplastic enamel-onycholysis-hypohidrosis syndrome |
| RS2108777804 |
MSX1
|
Health Risk |
Pathogenic |
— |
| RS2108778592 |
MSX1
|
Health Risk |
Pathogenic |
Orofacial cleft 5, Orofacial cleft 5 |
| RS2108778623 |
MSX1
|
Health Risk |
Pathogenic |
Oligodontia, Oligodontia |
| RS2108778725 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108783903 |
FGFR3
|
Health Risk |
Pathogenic |
— |
| RS2108787070 |
PIGG
|
Health Risk |
Pathogenic |
Emm-null phenotype, Emm-null phenotype |
| RS2108787283 |
MYLK
|
Health Risk |
Likely pathogenic |
— |
| RS2108788549 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108797528 |
FGFR3
|
Health Risk |
Likely pathogenic |
Achondroplasia, Achondroplasia |
| RS2108801356 |
PIGG
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS2108801803 |
TP63
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectrodactyly, ectodermal dysplasia |
| RS2108801923 |
TP63
|
Health Risk |
Likely pathogenic |
Rapp-Hodgkin syndrome, Rapp-Hodgkin syndrome |
| RS2108801985 |
TP63
|
Health Risk |
Likely pathogenic |
Split hand-foot malformation 4, Split hand-foot malformation 4 |
| RS2108804396 |
TP63
|
Health Risk |
Likely pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS2108804497 |
NSD2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2108804508 |
TP63
|
Health Risk |
Likely pathogenic |
TP63-related disorder, Ectrodactyly |
| RS2108804893 |
NSD2
|
Health Risk |
Pathogenic |
— |
| RS2108805626 |
NSD2
|
Health Risk |
Likely pathogenic |
Rauch-Steindl syndrome, Rauch-Steindl syndrome |
| RS2108805708 |
NSD2
|
Health Risk |
Pathogenic |
Syndromic intellectual disability, Syndromic intellectual disability |
| RS2108806204 |
TP63
|
Health Risk |
Pathogenic/Likely pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS2108806489 |
TP63
|
Health Risk |
Pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS2108806537 |
FGFR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Camptodactyly-tall stature-scoliosis-hearing loss syndrome |
| RS2108807160 |
FGFR3
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2108814954 |
PIGG
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS2108829049 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108829926 |
ATP13A3
|
Health Risk |
Likely pathogenic |
Pulmonary arterial hypertension, Pulmonary hypertension |
| RS2108832976 |
LETM1
|
Health Risk |
Pathogenic |
LETM1-associated clinical spectrum with predominant nervous system involvement, Neurodegeneration |
| RS2108833043 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108833230 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108833500 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108837611 |
CACNA1D
|
Health Risk |
Likely pathogenic |
— |
| RS2108838579 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108839112 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108840447 |
LETM1
|
Health Risk |
Pathogenic |
LETM1-associated clinical spectrum with predominant nervous system involvement, LETM1-associated clinical spectrum with predominant nervous system involvement |
| RS2108843144 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS2108843158 |
EVC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108843186 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108843224 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108846252 |
LETM1
|
Health Risk |
Pathogenic |
LETM1-associated clinical spectrum with predominant nervous system involvement, LETM1-associated clinical spectrum with predominant nervous system involvement |
| RS2108846393 |
LETM1
|
Health Risk |
Likely pathogenic |
LETM1-associated clinical spectrum with predominant nervous system involvement, LETM1-associated clinical spectrum with predominant nervous system involvement |
| RS2108846420 |
LETM1
|
Health Risk |
Pathogenic |
LETM1-associated clinical spectrum with predominant nervous system involvement, Neurodegeneration |
| RS2108847014 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108847232 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108847729 |
LETM1
|
Health Risk |
Pathogenic |
LETM1-associated clinical spectrum with predominant nervous system involvement, LETM1-associated clinical spectrum with predominant nervous system involvement |
| RS2108851273 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108851279 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108851441 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS2108851695 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108851802 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108861558 |
TP63
|
Health Risk |
Pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS2108863739 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108864342 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS2108864735 |
TP63
|
Health Risk |
Pathogenic/Likely pathogenic |
TP63-Related Spectrum Disorders, ADULT syndrome |
| RS2108864810 |
TP63
|
Health Risk |
Pathogenic |
Ectrodactyly, ectodermal dysplasia |
| RS2108864814 |
TP63
|
Health Risk |
Pathogenic |
Limb-mammary syndrome, Limb-mammary syndrome |
| RS2108864831 |
TP63
|
Health Risk |
Pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS2108864901 |
TP63
|
Health Risk |
Likely pathogenic |
— |
| RS2108869161 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2108873027 |
TP63
|
Health Risk |
Likely pathogenic |
TP63-Related Spectrum Disorders, TP63-related disorder |